Original Source(s)
Related Content
Can Belzutifan Improve Adjuvant Therapy?
The phase 3 LITESPARK-022 trial compared adjuvant pembrolizumab plus belzutifan with pembrolizumab plus placebo following resection of clear-cell renal-cell carcinoma.
July 8, 2026
-
4 min
Medical Oddities: When a Brush Beats a Scalpel
This research roundup has brain drama, bleeding control, skin science, and tiny brushes.
by Teraya Smith
July 7, 2026
-
5 min
Medical Oddities: Do Jellyfish Hold a Healing Secret?
Jellyfish, pets, watermelon, brain implants, and fennel fuel this week's surprises.
by Teraya Smith
July 1, 2026
-
5 min
